Transpek Industry submits EOI for Gopalpur manufacturing investment

Transpek Industry Limited has submitted an Expression of Interest (EOI) for a prospective investment in land and a manufacturing setup in Gopalpur, Odisha. The company disclosed that the submission is a preliminary step and does not tantamount to any final decision or approval regarding the investment. The potential expansion is subject to approval by its Board of Directors and the completion of internal due diligence processes.

Key Details of the Disclosure

The disclosure, submitted to BSE Limited, outlines the company's intent to explore new manufacturing capabilities. The following table summarizes the key aspects of the filing:

Particulars	Details
Activity	Submission of Expression of Interest (EOI)
Purpose	Prospective investment in land/manufacturing setup
Location	Gopalpur, Odisha
Status	Subject to Board approval and Internal Due Diligence
Filing Date	July 22, 2026

Conditions and Next Steps

The company emphasized that the EOI submission is merely an initial step. No investment decision has been taken or approved yet. The finalization of the prospective investment depends on two critical factors: the approval of the Board of Directors and the satisfactory outcome of internal due diligence. Shareholders should note that the project is at a nascent stage and may not materialize if these conditions are not met.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+4.19%	+3.82%	+6.48%	-6.33%	-6.33%	-6.33%

Transpek Industry Limited has accepted the resignation of Dr. Gurpreet Kaur from the position of Senior General Manager (R&D and QC), effective July 15, 2026. The resignation was tendered on July 13, 2026, citing professional circumstances, and the company confirmed she will be relieved from her duties at the close of business hours on the effective date. This development impacts the company's research and development leadership as it continues operations in the chemical sector.

The company submitted the intimation to BSE Limited pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made to inform the stock exchange about the change in senior management personnel. The company confirmed that the resignation has been accepted and the necessary details have been provided as per the regulatory requirements.

Dr. Gurpreet Kaur, who was heading the R&D and QC departments, submitted her formal resignation letter to the Managing Director. In her communication, she requested to be relieved of her duties by July 15, 2026. The company acknowledged the request and processed the resignation in accordance with the stated timeline. The resignation letter is attached as Annexure B to the regulatory filing.

The following table outlines the key details of the resignation as disclosed under SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026:

Sr. No.	Particulars	Information
1	Name	Dr. Gurpreet Kaur
	Reason for change	Resigned as Sr. General Manager (R&D and QC) due to professional circumstances.
2	Date of cessation	Resignation w.e.f., closure of business hours on 15/07/2026.
3	Brief profile	NA.
4	Disclosure of relationships	Not Applicable
5	Letter of Resignation	Attached as Annexure - B

The resignation was accepted by the company's human resources department. The acceptance was noted by Prashant Vaidya, Vice President (HR), on July 13, 2026. The company has ensured that all procedural formalities related to the exit of the senior management personnel have been completed. The information regarding the resignation is also available on the company's official website.